miércoles, 22 de enero de 2020

Funding deadline alert: Call for medical countermeasure regulatory science white papers

beta.SAM.gov

FDA Medical Countermeasures Initiative Update

White papers due by March 2, 2020, 5:00 p.m. ET

Call for white papers

FDA BAA: Advanced Research and Development of Regulatory Science

The FDA Medical Countermeasures Initiative (MCMi) Regulatory Science Program develops tools, standards, and approaches to assess medical countermeasure (MCM) safety, efficacy, quality, and performance.

In addition to funding FDA research, MCMi also funds external research partners to forward our goal of translating cutting-edge science and technology into innovative, safe, and effective MCMs.
 
Extramural MCM regulatory science is primarily funded through a Broad Agency Announcement (BAA), which has been updated for the current fiscal year, FY 2020. MCM-related areas of interest include:

  • Research Area 3: Support new approaches to improve product manufacturing and quality (for example, proposals to support advanced manufacturing for pandemic preparedness and response, or rapidly scale MCM manufacturing capabilities)
  • Research Area 7: Facilitate development and availability of MCMs to protect against threats to U.S. and global health and security
In FY 2020, FDA is encouraging the submission of chemical defense-related topics under Area 7. Proposers are encouraged to submit white papers by 5:00 p.m. ET, March 2, 2020, for consideration in FY 2020.

Questions? Contact us before you submit. Email AskMCMi@fda.hhs.gov to ask questions about MCM-related research areas or request an informal discussion prior to white paper submission.


Related links:


Events

Note: To reduce the length of this newsletter, descriptions for events have been shortened. You can find more information about these and other events on the MCMi News and Events page.




Information for industry

In case you missed it

No hay comentarios: